PubRank

A Taher

Author PubWeight™ 35.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genetic heterogeneity of Beta thalassemia in Lebanon reflects historic and recent population migration. Ann Hum Genet 2005 1.43
2 Interplay of structure and disorder in cochaperonin mobile loops. Proc Natl Acad Sci U S A 1996 1.10
3 Mechanical culture conditions effect gene expression: gravity-induced changes on the space shuttle. Physiol Genomics 2000 1.07
4 A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period. Clin Lab Haematol 2000 1.00
5 Compensatory changes in GroEL/Gp31 affinity as a mechanism for allele-specific genetic interaction. J Biol Chem 1999 0.98
6 Beta-thalassemia: the Lebanese experience. Clin Lab Haematol 2006 0.95
7 Deferasirox (Exjade) for the treatment of iron overload. Acta Haematol 2009 0.94
8 Beta-globin gene cluster haplotypes and HbF levels are not the only modulators of sickle cell disease in Lebanon. Eur J Haematol 2003 0.94
9 Unusual presentation of a sarcoid patient: multiple arterial and venous thrombosis with chest lymphadenopathy. J Thromb Thrombolysis 2008 0.93
10 Incidence of thromboembolic events in Lebanese thalassemia intermedia patients. Thromb Haemost 2003 0.90
11 Thiamine-responsive myelodysplasia. Br J Haematol 1998 0.90
12 High prevalence of Factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: is the eastern Mediterranean region the area of origin of this mutation? Thromb Haemost 2001 0.88
13 Intranuclear inclusions in megakaryocytes in congenital cytomegalovirus infection. J Pediatr 1978 0.87
14 Hughes syndrome associated with varicella infection. Rheumatol Int 2001 0.87
15 The AVAIL ME Extension: a multinational Middle Eastern survey of venous thromboembolism risk and prophylaxis. J Thromb Haemost 2011 0.87
16 Hepatitis-C-virus genotypes and hepatitis-G-virus infection in Lebanese thalassaemics. Ann Trop Med Parasitol 2002 0.86
17 Cancer in Lebanon: analysis of 10,220 cases from the American University of Beirut Medical Center. J Med Liban 1998 0.84
18 Long-term experience with deferasirox (ICL670), a once-daily oral iron chelator, in the treatment of transfusional iron overload. Expert Opin Pharmacother 2008 0.84
19 Combination cisplatin-vinorelbine for relapsed and chemotherapy-pretreated metastatic breast cancer. Am J Clin Oncol 1999 0.83
20 Idiopathic thrombocytopenic purpura and ovarian cancer. Eur J Gynaecol Oncol 2003 0.83
21 A comparison between prophylaxis and on demand treatment for severe haemophilia. Clin Lab Haematol 2005 0.82
22 Effects of CYP2B6 genetic polymorphisms in patients receiving cyclophosphamide combination chemotherapy for breast cancer. Cancer Chemother Pharmacol 2014 0.82
23 Cure of metastatic uterine carcinosarcoma to lungs: a case report. Int J Gynecol Cancer 2003 0.81
24 Breast cancer in Lebanon. Increased age-adjusted incidence rates in younger-aged groups at presentation: implications for screening and for Arab-American ethnic groups. Ethn Dis 2005 0.81
25 Relation of ferritin levels to pulmonary function in patients with thalassemia major and the acute effects of transfusion. Eur J Haematol 2000 0.81
26 Effect of oral iron chelation therapy with deferiprone (L1) on the psychosocial status of thalassaemia patients. Haematologia (Budap) 2002 0.80
27 Sickle cell disease: the Lebanese experience. Int J Lab Hematol 2007 0.80
28 Beta-thalassaemia intermedia in Lebanon. Eur J Haematol 2000 0.79
29 IgM myeloma and Waldenstrom's macroglobulinemia: a distinct clinical feature, histology, immunophenotype, and chromosomal abnormality. Clin Lab Haematol 2003 0.79
30 Hepatocellular carcinoma with isolated left adrenal metastasis following liver transplantation. Ann Saudi Med 2004 0.79
31 Prognostic index for primary adenocarcinoma of the urinary bladder. Gulf J Oncolog 2007 0.78
32 Survival and complications of beta-thalassemia in Lebanon: a decade's experience of centralized care. Acta Haematol 2008 0.78
33 Interferon alpha is an effective therapy for congenital dyserythropoietic anaemia type I. Eur J Haematol 2000 0.78
34 Genetic thrombophilia in patients with VTE in eastern Mediterranean located tertiary care center; is it time to change the algorithm for thrombophilia work up decision making? J Thromb Thrombolysis 2006 0.78
35 Beta-thalassemia mutations and haplotype analysis in Lebanon. Hemoglobin 2000 0.78
36 Endometrial metastasis from signet-ring breast carcinoma: case report. Eur J Gynaecol Oncol 2002 0.77
37 Infant mortality in Louisiana--identifying the risks. J La State Med Soc 2001 0.77
38 Speech defect associated with Class III jaw relationship. Plast Reconstr Surg 1997 0.77
39 Apoptosis in thalassemia major reduced by a butyrate derivative. Acta Haematol 2005 0.76
40 Diastolic dysfunction and pulmonary hypertension in sickle cell anemia: is there a role for L-carnitine treatment? Acta Haematol 2006 0.76
41 Phosphodiesterase isoenzymes in human ureteral smooth muscle: identification, characterization, and functional effects of various phosphodiesterase inhibitors in vitro. Urol Int 1995 0.76
42 Campylobacter fetus pericarditis in a patient with beta-thalassemia: case report and review of the literature. Clin Microbiol Infect 2001 0.76
43 Intracavernous application of SIN-I in rabbit and man: functional and toxicological results. Ann Urol (Paris) 1993 0.76
44 Posttransfusion graft-versus-host disease in two immunocompetent patients. J Am Acad Dermatol 1993 0.75
45 [Postural and kinetic tremor associated with vitamin B12 deficiency]. Rev Neurol (Paris) 2003 0.75
46 The relation between erythropoietin, hematocrit and hemoglobin in breast cancer patients on non-nephrotoxic chemotherapy. Eur J Gynaecol Oncol 1998 0.75
47 [A phlebocavographic evaluation of the size of the inferior vena cava for the placement of a DIL percutaneous caval filter. A preliminary study apropos of 10 cases]. Cah Anesthesiol 1991 0.75
48 The renal paracrine peptide system--possible urologic implications of urodilatin. World J Urol 1996 0.75
49 Cleidocranial dysplasia. Mymensingh Med J 2008 0.75
50 Transfusion-transmitted malaria: how vital is the need to screen in non-endemic countries? Transfus Med 2007 0.75
51 Familial antiphospholipid antibodies and acquired circulating anticoagulants. Lupus 2004 0.75
52 Detection of bleeding disorders in Lebanon: outcomes of a pilot programme. Haemophilia 2013 0.75
53 Novel mutation, L371V, causing multigenerational Gaucher disease in a Lebanese family. Am J Med Genet A 2004 0.75
54 Hydatid cyst mimicking acute chest syndrome in a sickle thalassemia patient. Ann Hematol 2007 0.75
55 Erythroblastic islands in erythroleukemia. Am J Pediatr Hematol Oncol 1981 0.75